NEXUS Attorneys has advised Steba Biotech group on its restructuring, particularly in connection with the liquidation of Swiss entities and the transfer of assets between companies. NEXUS Attorneys also advised Steba Biotech group on the conclusion of new strategic agreements in connection with its research activities. The team was lead by Nicolas F. Krauer.
